FRBT Forbright, Inc.

NEUTRAL Impact: 6/10 S-1/A
Horizon immediate Filed Jun 2, 2026 Processed 3d 8h ago SEC 0001628280-26-039673
IPO registration amendment

Executive Summary

Forbright, Inc., the bank holding company for Forbright Bank, is proceeding with its IPO of 7,900,000 shares of Class A common stock at an estimated price range of $18.00-$20.00 per share. The company has posted strong net income growth from $12.2M (FY2020) to $87.9M (FY2025), with total assets reaching $8.2B as of March 31, 2026. Proceeds of ~$138.2M (at the $19 midpoint) will be used for general corporate purposes. The offering is underwritten by major banks (Goldman Sachs, J.P. Morgan, Barclays) and includes Investor Rights Agreements with key pre-IPO investors, granting them board nomination rights and registration rights post-IPO.

Key Financial Metrics

Price Range
18.00-20.00

Actionable Insight

Monitor pricing range and final offer price for the IPO. Post-IPO, watch for the company's ability to sustain loan growth and net interest margin as well as any credit quality deterioration in the healthcare finance and lender finance portfolios, which represent ~50% of loans. The stock's performance will hinge on execution of digital deposit growth and fee income expansion.

Key Facts

  • Offering 7,900,000 shares of Class A common stock at $18-$20/share; IPO proceeds estimated at ~$138.2M (midpoint $19).
  • Net income grew from $43.4M (FY2024) to $87.9M (FY2025); total assets $8.2B as of March 31, 2026.
  • Digital deposit platform launched May 2024, reached $3.9B in deposits with ~95,000 accounts by March 31, 2026.
  • 91.5% of deposits are FDIC-insured; wholesale funding ratio decreased to 25% of total assets.
  • Underwriters (Goldman Sachs, J.P. Morgan, Barclays) have 30-day option to purchase up to 1,185,000 additional shares.
  • Company is an emerging growth company and will use reduced public company disclosure requirements.

Financial Impact

$138.2M in gross proceeds to the company at the $19 midpoint, before expenses.

equitybook value per sharedilution

Risk Factors

  • Concentration risk: healthcare finance is 31% of loan portfolio; single industry downturn could have outsized impact.
  • Interest rate sensitivity: large variable rate loan portfolio; net interest margin compressed from 3.78% (Q1 2025) to 3.10% (Q1 2026).
  • Regulatory risk: Company Tier 1 leverage ratio declined to 8.92%; entered CBLR grace period in Q1 2026.
  • Digital deposit retention risk: deposits are highly rate-sensitive; competitive pressures could raise funding costs.
  • Execution risk: expanding into new asset finance lending strategy and planned digital checking products.

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
S-1/A Filing (Primary)0001628280-26-039673
Exhibit: exhibit1013-sx1a.htm0001628280-26-039673
Exhibit: exhibit11-sx1a.htm0001628280-26-039673

US Market Status

Market Open — Closes in 7m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access